The Cellectis news from yesterday and subsequent Sangamo mention has Genomeweb.com placing SGMO is some heady company.
(snip)
Still, the Journal notes that a number of companies like Pfizer, AstraZeneca, Novartis, and Sangamo BioSciences and academic researchers are exploring gene editing, including using zinc finger nucleases and CRISPR.
https://www.genomeweb.com/scan/gene-editing-remission
No comments:
Post a Comment